Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Coffman

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Immunity|March 1, 2002
A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposureValerie Julia, Edith M Hessel, Laurent Malherbe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Friend of GATA is expressed in naive Th cells and functions as a repressor of GATA-3-mediated Th2 cell developmentHirokazu Kurata, Hyun-Jun Lee, Terri McClanahan, et al.
NPJ Vaccines|July 22, 2022
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in miceShirin Strohmeier, Fatima Amanat, John D Campbell, et al.
Cancer Research|June 28, 2018
Inhaled TLR9 Agonist Renders Lung Tumors Permissive to PD-1 Blockade by Promoting Optimal CD4<sup>+</sup> and CD8<sup>+</sup> T-cell InterplayMarilena Gallotta, Hikmat Assi, Émilie Degagné, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2006
Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responsesGail M Gauvreau, Edith M Hessel, Louis-Philippe Boulet, et al.
International Immunopharmacology|December 4, 2018
Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cellsSariah A Kell, Melissa A Kachura, Alex Renn, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cellsShu Wang, Jose Campos, Marilena Gallotta, et al.
The Journal of Experimental Medicine|March 9, 2005
T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cellsLinda Fahlén, Simon Read, Leonid Gorelik, et al.
The Journal of Experimental Medicine|December 1, 2010
Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9Cristiana Guiducci, Claudio Tripodo, Mei Gong, et al.
Clinical Immunology (Orlando, Fla.)|April 20, 2004
Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas diseaseSílvia de Barros-Mazon, Maria E Guariento, Cleide Aparecida da Silva, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Immunity|March 1, 2002
A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposureValerie Julia, Edith M Hessel, Laurent Malherbe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 24, 2002
Friend of GATA is expressed in naive Th cells and functions as a repressor of GATA-3-mediated Th2 cell developmentHirokazu Kurata, Hyun-Jun Lee, Terri McClanahan, et al.
NPJ Vaccines|July 22, 2022
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in miceShirin Strohmeier, Fatima Amanat, John D Campbell, et al.
Cancer Research|June 28, 2018
Inhaled TLR9 Agonist Renders Lung Tumors Permissive to PD-1 Blockade by Promoting Optimal CD4<sup>+</sup> and CD8<sup>+</sup> T-cell InterplayMarilena Gallotta, Hikmat Assi, Émilie Degagné, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2006
Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responsesGail M Gauvreau, Edith M Hessel, Louis-Philippe Boulet, et al.
International Immunopharmacology|December 4, 2018
Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cellsSariah A Kell, Melissa A Kachura, Alex Renn, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cellsShu Wang, Jose Campos, Marilena Gallotta, et al.
The Journal of Experimental Medicine|March 9, 2005
T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cellsLinda Fahlén, Simon Read, Leonid Gorelik, et al.
The Journal of Experimental Medicine|December 1, 2010
Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9Cristiana Guiducci, Claudio Tripodo, Mei Gong, et al.
Clinical Immunology (Orlando, Fla.)|April 20, 2004
Differential regulation of lymphoproliferative responses to Trypanosoma cruzi antigen in patients with the cardiac or indeterminate form of Chagas diseaseSílvia de Barros-Mazon, Maria E Guariento, Cleide Aparecida da Silva, et al.
Pageof 7